| ID Source | ID |
|---|---|
| PubMed CID | 81648 |
| CHEMBL ID | 3251113 |
| MeSH ID | M0146927 |
| Synonym |
|---|
| 1-(p-nitrophenyl)-3,3-dimethyl-triazen |
| n-methyl-n-[(e)-(4-nitrophenyl)azo]methanamine |
| triazene,3,3-dimethyl-1-(p-nitrophenyl) |
| 7227-92-1 |
| 1-(p-nitrophenyl)-3,3-dimethyltriazine |
| 3,3-dimethyl-1-(p-nitrophenyl)triazene |
| 1-(p-nitrophenyl)-3,3-dimethyltriazene |
| 1-p-nitrofenyl-3,3-dimethyltriazen |
| 1-(4-nitrophenyl)-3,3-dimethyltriazene |
| wln: wnr dnunn1&1 |
| 1-(p-nitrophenyl)-3,3-dimethyltriazen |
| nsc408428 |
| triazene,3-dimethyl-1-(p-nitrophenyl)- |
| 1-triazene,3-dimethyl-1-(4-nitrophenyl)- |
| 3,3-dimethyl-1-(4-nitrophenyl)triazene |
| nsc-408428 |
| 1-(p-nitrophenyl)-3,3-dimethyl-triazen [german] |
| 1-triazene, 3,3-dimethyl-1-(4-nitrophenyl)- |
| nsc 408428 |
| ccris 2076 |
| 1-(p-nitrophenyl)-3,3-dimethyl-triazene |
| 1-(4-nitrophenyl)-3,3-dimethyltriazine |
| triazene, 3,3-dimethyl-1-(p-nitrophenyl)- |
| 1-p-nitrofenyl-3,3-dimethyltriazen [czech] |
| 3,3-dimethyl-p-nitrophenyltriazene |
| (e)-3,3-dimethyl-1-(4-nitrophenyl)triaz-1-ene |
| n-methyl-n-[(4-nitrophenyl)diazenyl]methanamine |
| AKOS006274789 |
| CHEMBL3251113 |
| 1-p-nitrophenyl-3,3-dimethyltriazene |
| 3,3-dimethyl-1-p-nitrophenyltriazen |
| 3,3-dimethyl-1-(4-nitrophenyl)triaz-1-ene |
| DTXSID70879149 |
| Excerpt | Reference | Relevance |
|---|---|---|
| " The close correspondence of the two QSAR leaves essentially no means for the synthesis of more potent, less toxic triazenes." | ( Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in mice. Greenberg, N; Hansch, C; Hatheway, GJ; Quinn, FR, 1978) | 0.26 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1132824 | Toxicity in mouse L1210 cells allografted mouse assessed as mortality up to 5 days | 1978 | Journal of medicinal chemistry, Jun, Volume: 21, Issue:6 | Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice. |
| AID1148441 | Toxicity in rat assessed as concentration required for producing T/C of 140 | 1978 | Journal of medicinal chemistry, Jun, Volume: 21, Issue:6 | Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in mice. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.51) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||